반응식
[Br:1][C:2]1[CH:3]=[C:4]([N:11]=[N:12][N:13]2[CH2:17][CH2:16][CH2:15][CH2:14]2)[CH:5]=[C:6](I)[C:7]=1[O:8][CH3:9].CC1(C)C(C)(C)OB([C:26]2[O:27][C:28]([CH3:31])=[CH:29][CH:30]=2)O1>>[Br:1][C:2]1[CH:3]=[C:4](/[N:11]=[N:12]/[N:13]2[CH2:17][CH2:16][CH2:15][CH2:14]2)[CH:5]=[C:6]([C:26]2[O:27][C:28]([CH3:31])=[CH:29][CH:30]=2)[C:7]=1[O:8][CH3:9]참가 물질
3
실험 절차
1-((3-Bromo-5-iodo-4-methoxyphenyl)diazenyl)pyrrolidine (0.15 g, 0.366 mmol) and 4,4,5,5-tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane (0.076 g, 0.366 mmol), were reacted in the same manner as Example 1 Part B for 18 hours to give crude product which was purified on an Isco 12 g silica cartridge eluting with ethyl acetate/hexane (0% to 25%) to give the title compound.
후처리
- customto give crude product which
- customwas purified on an Isco 12 g silica cartridge
- washeluting with ethyl acetate/hexane (0% to 25%)
출처 및 근거
- ORD 기록
- ord-f77667acca784a0b90667e81daeb8b1a
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09353091B2
연결된 노트
불러오는 중…